Lucy Yang

Mechanisms Underlying Vascular Endothelial Growth Factor Receptor Inhibition–Induced Hypertension

I. Wilkinson, C. Schönlieb, C. McEniery, 2021, Hypertension.

Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.

Joseph Cheriyan, David E Newby, Ruth Tal-Singer, 2016, British journal of clinical pharmacology.

GLP‐1 Is a Coronary Artery Vasodilator in Humans

M. Bennett, N. Figg, C. Deacon, 2018, Journal of the American Heart Association.

Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers

R. Tal-Singer, D. Newby, R. Mayer, 2017, Chest.

Chemerin Elicits Potent Constrictor Actions via Chemokine‐Like Receptor 1 (CMKLR1), not G‐Protein‐Coupled Receptor 1 (GPR1), in Human and Rat Vasculature

Colin W. Taylor, A. Davenport, J. Maguire, 2016, Journal of the American Heart Association.

P29 MECHANISMS OF VASCULAR ENDOTHELIAL GROWTH FACTOR INHIBITION INDUCED HYPERTENSION

I. Wilkinson, C. McEniery, D. Jodrell, 2018 .

Lifestyle changes in atrial fibrillation management and intervention

M. Chung, Lucy Yang, 2023, Journal of cardiovascular electrophysiology.

The role of epoxyeicosatrienoic acids in the cardiovascular system

J Cheriyan, I. Wilkinson, C. McEniery, 2015, British journal of clinical pharmacology.